Japan Genitourinary Drugs Market Report 2016

November 2016 | 123 pages | ID: J6925E9ABA5EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Genitourinary Drugs

Revenue, means the sales value of Genitourinary Drugs

This report studies sales (consumption) of Genitourinary Drugs in Japan market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Astellas
• Pfizer
• GlaxoSmithKline
• Eli Lilly
• Bayer AG
• Merck
• Abbott Laboratories
• Bristol-Myers Squibb
• Genentech
• Roche
• Amgen
• Botex

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Sex Hormones
• Urologicals
• Genitourinary Anti-Infectives
• Gynaecologicals

Split by applications, this report focuses on sales, market share and growth rate of Genitourinary Drugs in each application, can be divided into

• Genitourinary Cancer
• Bladder Cancer
• Cervical Cancer
• Kidney/Renal Cancer
• Ovarian Cancer
• Prostate Cancer

Contents

Japan Genitourinary Drugs Market Report 2016

1 GENITOURINARY DRUGS OVERVIEW

1.1 Product Overview and Scope of Genitourinary Drugs
1.2 Classification of Genitourinary Drugs
  1.2.1 Sex Hormones
  1.2.2 Urologicals
  1.2.3 Genitourinary Anti-Infectives
  1.2.4 Gynaecologicals
1.3 Application of Genitourinary Drugs
  1.3.1 Genitourinary Cancer
  1.3.2 Bladder Cancer
  1.3.3 Cervical Cancer
  1.3.4 Kidney/Renal Cancer
  1.3.5 Ovarian Cancer
  1.3.6 Prostate Cancer
1.4 Japan Market Size Sales (Value) and Revenue (Volume) of Genitourinary Drugs (2011-2021)
  1.4.1 Japan Genitourinary Drugs Sales and Growth Rate (2011-2021)
  1.4.2 Japan Genitourinary Drugs Revenue and Growth Rate (2011-2021)

2 JAPAN GENITOURINARY DRUGS COMPETITION BY MANUFACTURERS

2.1 Japan Genitourinary Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 Japan Genitourinary Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 Japan Genitourinary Drugs Average Price by Manufactures (2015 and 2016)
2.4 Genitourinary Drugs Market Competitive Situation and Trends
  2.4.1 Genitourinary Drugs Market Concentration Rate
  2.4.2 Genitourinary Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 JAPAN GENITOURINARY DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 Japan Genitourinary Drugs Sales and Market Share by Type (2011-2016)
3.2 Japan Genitourinary Drugs Revenue and Market Share by Type (2011-2016)
3.3 Japan Genitourinary Drugs Price by Type (2011-2016)
3.4 Japan Genitourinary Drugs Sales Growth Rate by Type (2011-2016)

4 JAPAN GENITOURINARY DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 Japan Genitourinary Drugs Sales and Market Share by Application (2011-2016)
4.2 Japan Genitourinary Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 JAPAN GENITOURINARY DRUGS MANUFACTURERS PROFILES/ANALYSIS

5.1 Astellas
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Genitourinary Drugs Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Astellas Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Pfizer
  5.2.2 Genitourinary Drugs Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Pfizer Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline
  5.3.2 Genitourinary Drugs Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Eli Lilly
  5.4.2 Genitourinary Drugs Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Eli Lilly Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Bayer AG
  5.5.2 Genitourinary Drugs Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Bayer AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Merck
  5.6.2 Genitourinary Drugs Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Merck Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Abbott Laboratories
  5.7.2 Genitourinary Drugs Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Abbott Laboratories Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb
  5.8.2 Genitourinary Drugs Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bristol-Myers Squibb Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Genentech
  5.9.2 Genitourinary Drugs Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Genentech Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Roche
  5.10.2 Genitourinary Drugs Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Roche Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Amgen
5.12 Botex

6 GENITOURINARY DRUGS MANUFACTURING COST ANALYSIS

6.1 Genitourinary Drugs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Genitourinary Drugs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Genitourinary Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 JAPAN GENITOURINARY DRUGS MARKET FORECAST (2016-2021)

10.1 Japan Genitourinary Drugs Sales, Revenue Forecast (2016-2021)
10.2 Japan Genitourinary Drugs Sales Forecast by Type (2016-2021)
10.3 Japan Genitourinary Drugs Sales Forecast by Application (2016-2021)
10.4 Genitourinary Drugs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Genitourinary Drugs
Table Classification of Genitourinary Drugs
Figure Japan Sales Market Share of Genitourinary Drugs by Type in 2015
Figure Sex Hormones Picture
Figure Urologicals Picture
Figure Genitourinary Anti-Infectives Picture
Figure Gynaecologicals Picture
Table Application of Genitourinary Drugs
Figure Japan Sales Market Share of Genitourinary Drugs by Application in 2015
Figure Genitourinary Cancer Examples
Figure Bladder Cancer Examples
Figure Cervical Cancer Examples
Figure Kidney/Renal Cancer Examples
Figure Ovarian Cancer Examples
Figure Prostate Cancer Examples
Figure Japan Genitourinary Drugs Sales and Growth Rate (2011-2021)
Figure Japan Genitourinary Drugs Revenue and Growth Rate (2011-2021)
Table Japan Genitourinary Drugs Sales of Key Manufacturers (2015 and 2016)
Table Japan Genitourinary Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Genitourinary Drugs Sales Share by Manufacturers
Figure 2016 Genitourinary Drugs Sales Share by Manufacturers
Table Japan Genitourinary Drugs Revenue by Manufacturers (2015 and 2016)
Table Japan Genitourinary Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Japan Genitourinary Drugs Revenue Share by Manufacturers
Table 2016 Japan Genitourinary Drugs Revenue Share by Manufacturers
Table Japan Market Genitourinary Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Japan Market Genitourinary Drugs Average Price of Key Manufacturers in 2015
Figure Genitourinary Drugs Market Share of Top 3 Manufacturers
Figure Genitourinary Drugs Market Share of Top 5 Manufacturers
Table Japan Genitourinary Drugs Sales by Type (2011-2016)
Table Japan Genitourinary Drugs Sales Share by Type (2011-2016)
Figure Japan Genitourinary Drugs Sales Market Share by Type in 2015
Table Japan Genitourinary Drugs Revenue and Market Share by Type (2011-2016)
Table Japan Genitourinary Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Genitourinary Drugs by Type (2011-2016)
Table Japan Genitourinary Drugs Price by Type (2011-2016)
Figure Japan Genitourinary Drugs Sales Growth Rate by Type (2011-2016)
Table Japan Genitourinary Drugs Sales by Application (2011-2016)
Table Japan Genitourinary Drugs Sales Market Share by Application (2011-2016)
Figure Japan Genitourinary Drugs Sales Market Share by Application in 2015
Table Japan Genitourinary Drugs Sales Growth Rate by Application (2011-2016)
Figure Japan Genitourinary Drugs Sales Growth Rate by Application (2011-2016)
Table Astellas Basic Information List
Table Astellas Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Astellas Genitourinary Drugs Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Genitourinary Drugs Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Genitourinary Drugs Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Genitourinary Drugs Sales Market Share (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer AG Genitourinary Drugs Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Genitourinary Drugs Sales Market Share (2011-2016)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories Genitourinary Drugs Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Genitourinary Drugs Sales Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Genitourinary Drugs Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Genitourinary Drugs Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Genitourinary Drugs Sales Market Share (2011-2016)
Table Botex Basic Information List
Table Botex Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Botex Genitourinary Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Genitourinary Drugs
Figure Manufacturing Process Analysis of Genitourinary Drugs
Figure Genitourinary Drugs Industrial Chain Analysis
Table Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2015
Table Major Buyers of Genitourinary Drugs
Table Distributors/Traders List
Figure Japan Genitourinary Drugs Production and Growth Rate Forecast (2016-2021)
Figure Japan Genitourinary Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Japan Genitourinary Drugs Production Forecast by Type (2016-2021)
Table Japan Genitourinary Drugs Consumption Forecast by Application (2016-2021)